1. ScholarBank@NUS

Wee Joo Chng

rp04705

Collaboration Map View Statistics Email Alert RSS Feed

Profile

Full Name
Wee Joo Chng
Variants
Chng W.J
Chng, W.J.
Chng W.-J.
Wee Joo Chng
Chng, W.-J.
 
Main Affiliation
 
Faculty
 
Email
mdccwj@nus.edu.sg
 
Other emails
 

Publications

Results 121-140 of 183 (Search time: 0.013 seconds).

Issue DateTitleAuthor(s)
1212014Plasma cell neoplasms: Genetics, pathobiology, and new therapeutic StrategiesLee D.S.; Chng W.-J. ; Shimizu K.
1228-Oct-2019Pomalidomide and dexamethasone combination with additional cyclophosphamide in relapsed/refractory multiple myeloma (AMN001)-a trial by the Asian Myeloma NetworkSoekojo, Cinnie Yentia; Kim, Kihyun; Huang, Shang-Yi; Chim, Chor-Sang; Takezako, Naoki; Asaoku, Hideki; Kimura, Hideo; Kosugi, Hiroshi; Sakamoto, Junichi; Gopalakrishnan, Sathish Kumar; Nagarajan, Chandramouli; Wei, Yuan; Moorakonda, Rajesh; Lee, Shu Ling; Lee, Je Jung; Yoon, Sung-Soo; Kim, Jin Seok; Min, Chang Ki; Lee, Jae-Hoon; Durie, Brian; Chng, Wee Joo 
1232018Potential clinical application of genomics in multiple myelomaSoekojo, C.Y; de Mel, S; Ooi, M ; Yan, B; Chng, W.J 
1242018Preleukemic and second-hit mutational events in an acute myeloid leukemia patient with a novel germline RUNX1 mutationNg, I.K.S; Lee, J; Ng, C; Kosmo, B; Chiu, L; Seah, E; Mok, M.M.H ; Tan, K; Osato, M ; Chng, W.-J ; Yan, B; Tan, L.K 
1252016PRIMA-1 targets the vulnerability of multiple myeloma of deregulated protein homeostasis through the perturbation of ER stress via p73 demethylationTeoh P.J. ; Bi C.; Sintosebastian C.; Tay L.S. ; Fonseca R.; Chng W.J. 
1262015PRIMA-1met (APR-246) inhibits growth of colorectal cancer cells with different p53 status through distinct mechanismsLi, X.-L; Zhou, J ; Chan, Z.-L; Chooi, J.-Y ; Chen, Z.-R; Chng, W.-J 
1272015Primary Cutaneous NK/T-cell lymphoma, nasal type and cd56-positive peripheral t-cell lymphoma A cellular lineage and clinicopathologic study of 60 patients from AsiaTakata, Katsuyoshi; Hong, Mineui; Sitthinamsuwan, Panitta; Loong, Florence; Tan, Sooyong; Liau, Jauyu; Hsieh, Pinpen; Ng, Siok Bian ; Yang, Sheaufang; Pongpruttipan, Tawatchai; Sukpanichnant, Sanya; Kwong, Yoklam; Ko, Younghyeh; Cho, Yungtsu; Chng, Wee Joo ; Matsushita, Takashi; Yoshino, Tadashi; Chuang, Shihsung
1281-Nov-2022Prior Cancer Is Associated with Lower Atherosclerotic Cardiovascular Disease Risk at First Acute Myocardial InfarctionKoo, Chieh Yang ; Zheng, Huili ; Tan, Li Ling ; Foo, Ling-Li; Hausenloy, Derek J ; Chng, Wee-Joo ; Lee, Soo Chin ; Richards, Arthur Mark ; Ling, Lieng-Hsi ; Lim, Shir Lynn ; Lee, Chi-Hang ; Chan, Mark Y
1292019PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoproteinThura M.; Al-Aidaroos A.Q.; Gupta A. ; Chee C.E. ; Lee S.C. ; Hui K.M. ; Li J.; Guan Y.K. ; Yong W.P. ; So J. ; Chng W.J. ; Ng C.H. ; Zhou J. ; Wang L.Z. ; Yuen J.S.P. ; Ho H.S.S. ; Yi S.M.; Chiong E. ; Choo S.P. ; Ngeow J. ; Ng M.C.H. ; Chua C. ; Yeo E.S.A. ; Tan I.B.H. ; Sng J.X.E.; Tan N.Y.Z.; Thiery J.P. ; Goh B.C. ; Zeng Q. 
1302-Nov-2021PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein (vol 10, 2484, 2019)Thura, Min; Al-Aidaroos, Abdul Qader; Gupta, Abhishek ; Chee, Cheng Ean ; Lee, Soo Chin ; Hui, Kam Man ; Li, Jie; Guan, Yeoh Khay ; Yong, Wei Peng ; So, Jimmy; Chng, Wee Joo ; Ng, Chin Hin ; Zhou, Jianbiao ; Wang, Ling Zhi; Yuen, John Shyi Peng; Ho, Henry Sun Sien ; Yi, Sim Mei; Chiong, Edmund ; Choo, Su Pin ; Ngeow, Joanne; Ng, Matthew Chau Hsien ; Chua, Clarinda; Yeo, Eugene Shen Ann ; Tan, Iain Bee Huat ; Sng, Joel Xuan En; Tan, Nicholas Yan Zhi; Thiery, Jean Paul ; Goh, Boon Cher ; Zeng, Qi 
13126-Aug-2021Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trialsChen, Yan-Ting; Valent, Erik T; van Beers, Erik H; Kuiper, Rowan; Oliva, Stefania; Haferlach, Torsten; Chng, Wee-Joo ; van Vliet, Martin H; Sonneveld, Pieter; Larocca, Alessandra
1322014Prognostic implication of morphology, cyclinE2 and proliferation in EBV-associated T/NK lymphoproliferative disease in non-immunocompromised hostsNg, S.-B ; Ohshima, K; Selvarajan, V ; Huang, G; Choo, S.-N; Miyoshi, H; Wang, S ; Chua, H.-C ; Yeoh, A.E.-J ; Quah, T.-C ; Koh, L.-P ; Tan, P.-L ; Chng, W.-J 
1332019Proteolysis targeting chimeric molecules as therapy for multiple myeloma: Efficacy, biomarker and drug combinationsLim, S.L.; Damnernsawad, A.; Shyamsunder, P. ; Chng, W.J. ; Han, B.C.; Xu, L. ; Pan, J.; Pravin, D.P. ; Alkan, S.; Tyner, J.W.; Koeffler, H.P. 
134Oct-2020Rapid production of clinical-grade SARS-CoV-2 specific T cells.Leung, Wing; Soh, Teck Guan; Linn, Yeh Ching ; Low, Jenny Guek-Hong ; Loh, Jiashen; Chan, Marieta; Chng, Wee Joo ; Koh, Liang Piu ; Poon, Michelle Li-Mei; Ng, King Pan ; Kuick, Chik Hong; Tan, Thuan Tong ; Tan, Lip Kun ; Seng, Michaela Su-Fern 
13528-Jan-2021RAS-protein activation but not mutation status is an outcome predictor and unifying therapeutic target for high-risk acute lymphoblastic leukemiaKoschut, David; Ray, Debleena; Li, Zhenhua ; Giarin, Emanuela; Groet, Jurgen; Alic, Ivan; Kham, Shirley Kow-Yin; Chng, Wee Joo ; Ariffin, Hany; Weinstock, David M; Yeoh, Allen Eng-Juh; Basso, Giuseppe; Nizetic, Dean
1362017Recent advances in acute promyelocytic leukaemiaNg, C.-H ; Chng, W.-J 
1372-Feb-2018Recent Advances in the Management of Multiple Myeloma: Clinical Impact Based on Resource-stratification. Consensus Statement of the Asian Myeloma Network at the 16th International Myeloma WorkshopDaryl Tan; Jae Hoon Lee; Wenming Chen; Kazuyuki Shimizu; Jian Hou; Kenshi Suzuki; Weerasak Nawarawong; Shang-Yi Huang; James Chim; Kihyun Kim; Pankaj Malhotra; Lalit Kumar; Wee Joo Chng ; Brian Durie
1381-Aug-2020Recommendations to improve the clinical adoption of NGS-based cancer diagnostics in SingaporeTan, David Shao-Peng; Tan, Daniel Shao-Weng; Tan, Iain Bee Huat ; Yan, Benedict; Choo, Su Pin ; Chng, Wee Joo ; Hwang, William Ying Khee
139Aug-2013Recurrent chromosome abnormalities define nonoverlapping unique subgroups of tumors in patients with chronic lymphocytic leukemia and known karyotypic abnormalitiesJimenez-Zepeda, V.H.; Chng, W.J. ; Schop, R.F.J.; Braggio, E.; Leis, J.F.; Kay, N.; Fonseca, R.
1401-Sep-2022REIIBP promotes TLR7-BTK-IL6 pro-inflammatory response through histone H3 lysine methylation in t(4;14) myelomagenesisChong, Shu Yun Phyllis ; Chng, Wee-Joo ; Lim, Sze Lynn Julia